ArticleScientific reports2025
Correlation of fibrinogen levels with acute myocardial infarction risk in the Chinese Han population.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Translocator Protein Modulation by PK11195 and NO Synthase Inhibition Affect Cardiac Oxidative Stress and Cardiometabolic and Inflammatory Markers in Isoprenaline-Induced Rat Myocardial Injury.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To evaluate the correlation between plasma fibrinogen levels and acute myocardial infarction (AMI) in the Chinese Han population. A total of 1522 patients with incident AMI and 6125 controls were recruited between January 1, 2010, and December 31, 2013. The relationship between fibrinogen levels and incident AMI was evaluated using multivariable-adjusted logistic regression, and the possible interaction effects between fibrinogen and other risk factors on incident AMI were investigated. When modeled as a continuous variable, a 1 g/L increase in fibrinogen level was associated with a 91% increase in the risk of AMI [odds ratio (OR):1.91; 95% confidence interval (CI):1.63-2.23 in women, 1.86:1.70-2.03 in men, and 1.85:1.72-2.00 in total]. Compared to 1st quartile of fibrinogen levels, the adjusted ORs for first incident AMI was 3.25 (2.67-3.96) for the fourth quartile, 1.61 (1.30-1.99) for the third one, 1.18 (0.96-1.46) for the second one (P < 0.001). High fibrinogen levels are associated with an increased risk of incident AMI in the Chinese Han population, and fibrinogen could be an important biomarker for AMI risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.